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Background: In Europe, Spain has the highest number of people with Chagas disease (CD). Bolivian migrants
account for 81% of the reported cases. One of the priorities in controlling the disease is prevention of mother-
to-child transmission. Despite under-diagnosis in Spain being estimated at 90%, there are currently few
studies that explore the social and cultural dimensions of this disease.
Objective: The aim of this study was to explore the knowledge and experiences of Bolivian women with CD, in
order to generate a useful understanding for the design and implementation of public health initiatives.
Design: Qualitative study based on semi-structured interviews, triangular groups, and field notes.
Participants: Fourteen Bolivian women with CD living in Madrid.
Results: The participants were aware that the disease was transmitted through the vector, that it could be
asymptomatic, and that it could also be associated with sudden death by heart failure. They opined that
the treatment as such could not cure the disease but only slow it down. There was a sense of indifference along
with a lack of understanding of the risk of contracting the disease. Participants who presented with symptoms,
or those with relatives suffering from the disease, were concerned about fatalities, cardiac problems, and
possible vertical transmission. There was also a fear of being rejected by others. The disease was described
as something that affected a large number of people but only showed up in a few cases and that too after many
years. There was a widespread assumption that it was better not to know because doing so, allows the disease
to take hold.
Conclusions: Disease risk perception was very low in Bolivian women living in Madrid. This factor, together
with the fear of being screened, may be contributing to the current rate of under-diagnosis.
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Introduction
Chagas disease (CD) is a parasitic infection caused by
Trypanosoma cruzi (T. cruzi) and is endemic to regions in
Latin America. It is transmitted mostly in rural areas by
a vector Triatoma infestans (T. infestans). Transmission
via blood transfusion, transplants, and mother to child is
also possible. Most people remain asymptomatic after
infection and one-thirds will develop chronic heart and/or
bowel disease. Treatment with benznidazole or nifurti-
mox is extremely toxic and has limited effectiveness when
the disease is chronic. However, it is effective in the
reduction of congenital transmission.
According to the World Health Organization (WHO),
there are more than 10 million people infected by T. cruzi
and the majority live in Latin American countries (1). In
Europe, Spain has the largest number of Latin American
migrants, more than 2 million (2), which is why it is the
European country with the highest number of CD cases
(3, 4). According to the available data, there are more than
50,000 people infected by T. cruzi in Spain (5) out of
which, 60% are women of child-bearing age (3). The
estimated average rate of congenital transmission is 4.35%
(57). Majority of diagnosed Chagas cases in Spain (81%)
are amongst the 190,000 Bolivians living in the country
(3). The prevalence of infection in this population is
estimated to be over 20% (5).
In Spain, all blood products and organs are screened
for CD (8, 9). There are also some regional initiatives to
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screen the other possible mode of transmission: congeni-
tal transmission during pregnancy. Nonetheless, with
under-diagnosis estimated to be at 90% (3, 5), there is
no national plan for the control of CD. Moreover, there
are few qualitative studies offering a social and cultural
dimension of this disease in immigrants living in Spain
(1012).
The aim of this study is therefore to explore the
knowledge and experiences of a group of Bolivian
women with CD living in Madrid in order to generate a
useful understanding for the design of public health
policies adapted to the social and cultural context of the
population at risk.
Design
This is a qualitative study with a constructionist perspec-
tive where Grounded Theory has been used to analyse
data (13). Grounded Theory is an analytical process based
on the symbolic interactionism tradition. It consists
of coding the information collected in successive steps
and from an inductive perspective in order to create
a general theory (13). In this case, we use Grounded
Theory to identify knowledge and experiences of Chagas
and relate this to explicative variables. Data were gathered
through semi-structured interviews; the key questions
to be asked were decided on in advance and a detailed
interview structure was created. Triangular groups, an
alternative to focus groups, were also used in order
to merge the individual and the group discourse. Trian-
gular groups are composed of fewer people and their
dynamic is less structured than in focus groups (14).
Observation field notes were employed as a complemen-
tary technique (15).
Scope of the study
The study was carried out in the Community of Madrid
(CM). Part of the research was framed within one of the
health programmes created by the Fundación Mundo
Sano, which focused on training a group of Bolivian
women living in the CM to become community health
workers. The study was developed in different public
health facilities, administrative centres, and the National
Centre for Tropical Medicine, as well as the private homes
of the participants.
Study subjects
Women were selected from different public healthcare
centres and via the Association of Friends of People with
CD (ASAPECHA in Spanish). The criteria for inclusion
were: being a woman from Latin America and to have
attended a Chagas screening service.
Field work
Fourteen interviews were performed in total, as well as
two triangular groups (Table 1). Sixteen field notes were
collected during the training programme. A summary of
the key topics introduced during the course of the
interviews and the triangular groups is provided (Table 2).
Field work was developed in two stages. The first of
these was the period from March to September 2013,
during the training course. Once all the data had been
analysed in detail, we initiated the second stage of the
study, from November 2013 to March 2014, in order to
reach data saturation (16).
Data analysis
Analysis of the data was performed using the OpenCode
3.6 programme of the University of Umea, Sweden.
For analysis of the initial interviews, codes of meaning
were identified and later grouped into categories which
were then developed and applied to the social context
of Bolivia and Spain. Through these means, theories
surrounding the meanings expressed by the participants
were generated. These theories were tested in subsequent
interviews and the material obtained in these encounters
was again codified and added to the previous analyses.
Scientific rigour
All research was conducted in Spanish. An external expert
transcribed all the interviews. Transcriptions were sub-
jected to quality control through a further listening of
the recording and the correction of any errors. Finally, the
interviews were translated into English for publication.
In order to provide concrete findings, data sources
and analyst triangulations were carried out (17): the infor-
mation gathered was verified and compared at different
points by means of the field notes collected throughout
the training programme. Additionally, analysis was
undertaken independently by three researchers, allowing
for the identification and management of discrepancies
within the codification.
Ethical considerations
Ethical clearance for the study protocol was approved
by the Ethical Committee of the Health Institute Carlos
III (Spain). Informed written consent to use and publish
their discourses was obtained from all participants in the
study. Personal data were managed according to Spanish
legislation (18).
Results
Knowledge of the disease
With regard to transmission, participants with a higher
level of education were particularly concerned with the
vector-borne transmission and its prevalence in rural life.
They made specific reference to the dangers of houses
made of adobe (sun-dried bricks), beds with straw
mattresses, and proximity to animals. Participants were
familiar with T. infestans (commonly known as vinchuca in
Bolivia), and its link to the transmission of the disease.
Nevertheless, little was known specifically about how the
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parasites entered the blood stream. Even if doubts
remained surrounding the possibility of vector-borne
transmission in Spain, participants felt that it was unlikely
to happen due to colder weather, which prevents the
existence of the vinchuca. They knew that the disease was
not transmitted person-to-person. They were also aware of
the risk of vector-borne transmission and transmission via
blood transfusions; however, they hardly mentioned the
possibility of transmission due to ingestion.
While I was sleeping, it would bite me and I’d grab it
and pull its head off and throw it on the floor . . . as
my house was made of adobe, it was a mud-roofed
house and, because of this, there were quite a few
vinchucas. (Woman, age 45)
Thanks God it is not contagious. (Woman, age 44)
However, participants with a lower level of education
were unaware of the risk of vector-borne transmission
when they lived in Bolivia and, at the time of the
interview, they believed incorrectly that the disease could
be transmitted through interpersonal contact.
Ever since I was little I’ve known about the
vinchuca, it would bite me . . . because when we
are little we don’t know whether it causes the disease
or not . . . even now, my mother doesn’t know if it
causes the disease. (Woman, age 45)
I wonder if I can pass it on to them or something
[talking about her children]. I mean, I am always
thinking about it and that is why I have my own
glass and I want to be the only one who drinks from
it . . .. (Woman, age 33)
With regards to the symptoms, the disease was viewed as
something that affected a lot of people but only showed up
in a few and that too after many years. When the disease
presented itself, it caused death due to heart failure or
alterations in the intestine.
It is a disease that, sometimes, in most people, does
not show up, as people say . . . And then, in one, in
one or two people, it can show up and they can
actually die of . . . of a heart attack, I’ve been told.
(Woman, age 31)
With regards to the diagnosis, they were aware that
detection of the disease was made via a blood test.
However, others believed, incorrectly, that it could be
detected through urine or faeces. Not all of them knew
that a specific test for CD was necessary in order to detect















Participants in E1 31 Cochabamba Secondary education Housekeeper Yes 2 10 H
the training E2 31 Cochabamba Secondary education Unemployed Yes 2 10 H
programme E3 35 Cochabamba Secondary education Housekeeper Yes 2 10 H
E4 34 Cochabamba Secondary education Housekeeper Yes 1 15 H
E5 47 Cochabamba Secondary education Housekeeper Yes 3 9 H
E6 28 Santa Cruz Secondary education Housekeeper Yes 1 6 HC
Other E7 47 Cochabamba Secondary education Housekeeper Yes 3 9 H
participants E8 50 Trinidad/
Santa Cruz
Secondary education Unemployed Yes 5 9 R
E9 44 Santa Cruz Secondary education Beautician Yes 1 13 HC
E10 34 Cochabamba/
Santa Cruz
Secondary education Housekeeper Yes 3 9 HC
E11 42 Vallegrande/
Santa Cruz
Primary education Housekeeper Yes 3 7 HC
E12 45 Cochabamba Primary education Housekeeper Yes 4 9 H
E13 33 Santa Cruz Primary education Housekeeper Yes 3 10 A
E14 35 Santa Cruz Primary education Housekeeper Yes 3 9 A
Triangular 31 Cochabamba Secondary education Housekeeper Yes 2 10 H
Group 1 34 Cochabamba Secondary education Housekeeper Yes 1 15 H
47 Cochabamba Secondary education Housekeeper Yes 3 9 H
Triangular 28 Santa Cruz Secondary education Housekeeper Yes 1 6 HC
Group 2 31 Cochabamba Secondary education Housekeeper Yes 2 10 H
31 Cochabamba Secondary education Unemployed Yes 2 10 H
A, association; H, hospital; HC, Healthcare centre; R, other participant’s relative.
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infection; they thought that it could be detected through
any blood test.
A long time ago, I thought that a simple blood test
would be able to detect it [. . .] that is why I tell
people that they need to get tested [. . .], I mean, for
Chagas. (Woman, age 34)
Regarding treatment, there were doubts about its effec-
tiveness, duration, side effects, and cost. In general,
they knew it did not cure the disease but that it could
slow it down and that it was more effective in children
and also in adults with a less advanced form of the
disease. Trust in the treatment was variable and the
motivation for following it was based primarily on
blind trust. Even when they knew that the treatment
was not 100% effective, the majority of them were
accepting of it and were convinced that it would work
for them (Table 3).
Basically I understood that the drugs that I am
going to take are meant to do kind of keep this . . .
parasite in a balloon. It stays there, in the balloon,
kind of separated. So it will affect me as little as
possible. (Woman, age 34)
There is a lack of criticism by some participants regarding
the limited visibility of CD. Despite the fact that the
treatment is very old and that there have been no new
drugs created to treat it, they declared that those currently
available must be good enough.
The only thing is that the treatment has been around
a long time [. . .] since 1969 and then they came up
with this new one . . . and after this one, no . . . they
haven’t brought out any new treatment [. . .]. It must
be good! (Woman, age 44)
Concerns and consequences of the disease
Awareness of CD
Most of the participants were diagnosed during a routine
medical check-up, pregnancy check-up, or blood dona-
tion, and had no perception of the risk at the point of the
diagnosis. It is surprising that in some cases the individual
had tested positive for Chagas in Bolivia but had not paid
much attention to the diagnosis at the time. In other cases,
they were the ones who took the initiative of asking for the
test (Fig. 1). In these cases, the most important factor in
becoming aware of the risk of the disease was to have
witnessed the death or illness of a close relative. The
decision to get tested was also determined by whether they
were aware that treatment was available that could slow
down the progression of the disease. Moreover, a woman
explained that an article in a Latin American newspaper
talking about CD had changed her perception of the risks.
It was about 19 years ago . . . my oldest son had an
accident and needed a blood transfusion from me. It
was at that time that I realised I had Chagas [. . .] and
Table 2. Main topics included in the interview and group’s
guidelines
Knowledge and perceptions
Transmission: vector, other transmission routes, possibility of
transmission in Spain
Symptoms and diagnosis
Treatment and its side effects
Personal and social experiences
How the diagnosis was performed and the reasons for
undergoing the test
The meaning of Chagas disease
The moment of the diagnosis
Experience of the disease and treatment
Consequences of the disease for their own lives and that of
others
Social support and people consulted for health-related advice
Social rejection caused by the disease
Disease representation in Spain and in Bolivia
Memories of their lives in Bolivia
Social representations of the disease in Spain
Table 3. Considerations of participants regarding the effectiveness of treatment
There is a cure E1, E8, E9, E10, E11, E13: Significant trust in the treatment.
Treatment does not cure; it slows it down or has
other benefits
E2: (After receiving information) It reduces vertical transmission, it slows down the
disease. Is there a cure?
E4: If the disease is not advanced, treatment isolates it, like putting it in a balloon, so it
cannot affect me.
E5, E7: (After receiving information) It slows it down so that it is not transmitted from
generation to generation.
E6: It can be remedial, in some people it can slow down the disease.
E12, E14: A lot of uncertainty about whether the treatment can cure the disease.
There is no cure E2, E3: (Once diagnosed) There is no cure, it is not worth getting tested.
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the truth is that back in Bolivia, Chagas was seen as
nothing major. [. . .] No, there wasn’t that much
alarm at that time [. . .] That was it! I never got to go
to . . . the centre to do . . . for them to confirm [. . .]
I forgot about it later on! [. . .] When I arrived in
Spain [. . .], I happened to glance at a Latin American
newspaper and, there you go . . . and then I felt a bit
scared . . . they called it the ‘silent disease’. . . a lot of
people die in Bolivia because of this disease, which is
not considered very important . . . but they encou-
rage people to go [. . .] to get tested. And I didn’t
hesitate! I didn’t hesitate . . . I went to do the test and
I tested positive. (Woman, age 50)
The experience of living with CD and its consequences
When the women were informed about the Chagas
diagnosis, different types of feelings arose, ranging from
concern to indifference.
It didn’t affect me . . . No, because I didn’t know what
disease it was. I believed it was something that didn’t
. . . something that had a cure . . . I didn’t really know
what . . . what it really was. (Woman, age 31)
The only thing that she told me was, ‘Ah but . . .
back there everyone has Chagas and it’s OK.’
(Woman, age 34)
Amongst other women with symptoms or with more
information, there was concern about reduced life expec-
tancy and heart problems. Concerns of the participants
were mostly surrounding possibly having passed the
disease on to their children and the worry of not being
able to look after them in the future.
When they told me I had Chagas, I thought that by
the time I’m my mother’s age . . . I am also going to


































Doctor friend of her father
Convinced by her mother
Time living in Bolivia Time living in Spain
Asymptomatic
Symptomatic
Test performed as part of check-up or medical study
Test performed at the patient’s request
Test requested by patient and not performed by her doctor
Fig. 1. Moment of testing and reason as to why participants underwent Chagas testing.
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[. . .] That’s something that scares me. (Triangular
Group 1)
The experience of the treatment was negative or positive
depending on whether or not there were side effects. In
some cases, these side effects were very important.
What’s more, you feel powerless because [. . .] they
prescribed me the treatment and [. . .] I couldn’t even
manage to do half of it. Then, to know that . . . my
body has refused the treatment, it also bothers me,
right? It bothers me because I’ve taken so much
medicine my whole life [. . .] I am not allergic to any
medicine. That’s weird, right? (Triangular Group 1)
The motivation to begin treatment was linked to their
children, the level of concern they had for the disease,
and to the level of trust in the treatment. Additionally,
the treatment was perceived as the only option that would
improve their chances of living long enough to see their
dreams and ambitions come true.
Your only alternatives are to take the treatment or
not to take anything. If you don’t take anything, it is
worse because you are not taking any action. If you
are going to take the treatment, you have a chance,
and even more being here (Spain), where you are
monitored, where you can . . . you have the support
of the doctors. (Triangular Group 2)
However, they also expressed reasons not to seek treatment.
These were linked to uncertainty surrounding its effec-
tiveness, side effects, supply shortages, not having anyone
to leave their children with, and not having enough time
to attend check-ups.
There weren’t going to allow me to go to. I don’t
know how many doctors . . . And that is the reason
why I didn’t . . . I left it. (Woman, age 31)
Another consequence of the disease was the fear of being
shunned by Spaniards and by those Latin Americans
who were unaware of CD and its mode of transmission.
This explains why all the women who were interviewed
revealed that they were hiding the disease, especially
in their work environment. Nevertheless, they were
less concerned about other people from Bolivia finding
out, because they felt that Bolivians did know about the
disease.
Among our people, I mean, those who really are ‘us’
 that is, the Bolivians  they know the disease, so,
there is no problem if you want to tell them . . . they
accept you as you are. We know, more or less . . . I
mean, at least we have an idea of what the disease
is, right? We know it isn’t contagious or anything.
Eh . . . Ah . . . I mean, contagious . . . by talking to
people or by touching someone, it isn’t contagious
but, when talking to other kinds of people who
don’t have the same nationality as you, then . . . at
least that is what I have felt, you know? (Triangular
Group 1)
They were also afraid of being rejected by people from
Bolivia due to the connection between CD and poverty.
Every time I have spoken about Chagas, people
tell me . . . Actually, I think they have this idea,
like . . . [clicking sound] . . . ‘that [happens] to
you [Bolivians], because you are so poor.’ (Woman,
age 28)
The link between poverty and the disease was evident
in the discussions, particularly in the way the women
attempted to distance themselves from any connection
with a poor or rural background. They would try to look
for another explanation for their own infection such
as having contracted the disease through their mothers
during pregnancy.
The old one [house], yes, that was made of adobe
[. . .]. We are from the city, always from the city
centre [. . .] And I wonder how I could’ve been bitten
by one of those. I was living in the city, I mean, I
have always been from the city. And I don’t have any
relatives in the countryside, right? Because my
grandmother was from the city, from the city centre
[. . .]. Since I found out that my mother has it
[Chagas], I think it was her who gave it to me during
pregnancy. (Woman, age 47)
Participants described instances of being the object
of discrimination following the disclosure of their CD.
For example, a participant revealed her diagnosis to
her house mates and, within a couple of days, they left the
house without giving any explanation. Another woman
recounted that colleagues at her place of work had
separated the kitchen utensils she had been using from
their own.
Because the mistake I made was to tell people at
work last year . . . and, my colleagues, they were
so ignorant that they even put the glasses aside.
(Woman, age 44)
The social representation of the disease
Participants acknowledged that they came from a region
where the vinchuca lives and where CD is endemic. This
was part of their everyday environment and they had a
perception of CD as something common, something
that a lot of people had but rarely suffered from. They
believed that only some people experience symptoms in
later life.
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Her grandmother is around sixty or seventy years
old and she is very well; and she has that disease.
(Woman, age 31)
However, there was a contrasting discourse focused on
a fear of Chagas, which was largely the result of having
been close to a person with the disease, or to someone
who had died suddenly due to cardiac problems.
Everybody has that disease and nothing happens . . .
And I say, OK but my mother has it and she is
having a bad time. (Woman, age 34)
While there was a sense of indifference towards the disease
prior to the diagnosis, there was a sudden association with
death upon confirmation of the infection. This was evident
in the experiences of the participants as well as those
of their families.
I feel very bad. No, actually I was fine when this
disease wasn’t here, I was fine, now it is here and I
feel bad. I feel bad. What makes you feel bad?
Because maybe I am going to die [she cries] [. . .] I
don’t know what I am going to do, sometimes I
think that I am going to die at any moment.
(Woman, age 45)
Women tend to protect themselves, thinking it is better
not to know of the diagnosis as if they felt that being
aware of the disease would make it grow.
You feel healthy and then someone tells you that
you have something. Everything is psychological too
so, by saying it, you get ill straight away. It is better
not to know and not to worry [. . .]. If you think
about it, you draw it towards you. And that is why
people say it is better not to know. (Woman, age 42)
Interestingly, participants considered that people from
Bolivia were irresponsible and careless with regards to
their own health. Nevertheless, they pointed out that
if the healthcare system in Bolivia were free and of good
quality, they would look for healthcare assistance.
If the treatment were free, or even if you had to pay
a little, but not much, people would do it [. . .]
[people] would care [about their own health] but




The interviewees are highly familiar with vector-born
transmission as it is endemic to the regions they are from
(19, 20). However, as has already been reported in other
research studies conducted in endemic and non-endemic
areas, they have a poorer understanding of the symptoms,
the diagnosis, the transmission routes and the treatment
(12, 21). These gaps in their knowledge are not only
related to their level of education but may also be
explained by the difficulties that arise surrounding
doctorpatient communication or the lack of awareness
of the disease among healthcare workers (22). As the
women who participated in this study had repeatedly
visited healthcare services in Spain to treat their CD,
their lack of knowledge could be related to the lack of
information provided by these professionals. Therefore, it
is very important that people working in healthcare
services develop their awareness of the disease and its
social consequences. Furthermore, they should possess
the necessary tools to be able to give effective information
to their patients.
Significantly, we found that there is confusion sur-
rounding treatment. This seems understandable given the
high level of uncertainty that currently exists regarding
its effectiveness. Therefore, public health campaigns need
to communicate clearly the positive outcomes in the
prevention and control of congenital CD (23). Given
that the biggest concern for our participants was their
children, these messages could have a very positive effect
on the wider population infected by T. cruzi.
It is interesting to highlight the absence of criticism
surrounding the limited visibility of CD and of the drugs
that are currently available. The participants never
mentioned the inefficiencies of the government in mana-
ging the disease or the pharmaceutical industry’s general
lack of interest in researching for new drugs (24). These
factors are common in neglected diseases whereby the
affected population is characterised by an inability to
react (24, 25).
Concerns and consequences of the disease
One of the most important findings from this study is the
women’s limited understanding of the risks associated
with CD before being diagnosed. The fact that people
remain asymptomatic for a long period of time could
explain this, as well as the lack of awareness of the disease
(11, 26).
Our data provide evidence of the close relationship
between lack of awareness of the disease and the social
representation of CD in Bolivia, where it is perceived as
a common and even relatively harmless condition.
Consequently, we would expect that people will act in
accordance to this social representation (27) and that it
could be a determining factor in Bolivian migrants being
less likely to access healthcare facilities and to ask for a
screening test.
Other explanations behind the lack of awareness of the
disease amongst women from urban areas of Bolivia
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could lie in the fact that they relate Chagas to their
conception of rural life. This idea could mistakenly
lead people to associate the disease with rural areas.
This could in turn make people from urban areas feel
an illusionary invulnerability to the disease and conse-
quently refrain from taking preventive measures (21).
Currently, a high percentage of Chagas cases are diag-
nosed in Bolivian cities (28, 29).
The low level of risk awareness that is reported in this
study suggests the need to implement health education
campaigns about the risk factors for acquiring the disease
and the importance of early diagnosis. At present, there
are few health education initiatives in Spain and those
that do exist are only at a local level (30).
Our research provides evidence that the biggest con-
cerns felt by the women  both at the time of the
diagnosis and afterwards  surround their children. As
other studies have already demonstrated (10, 31), a sense
of responsibility and guilt appears to be caused by the
fear of having passed the disease on to their children and
of not being able to look after them if they become ill.
Concern and uncertainty surrounding treatment was
also reported. The interviewed women gave reasons for
not adhering to treatment which have also been well
documented in the wider research. These included the
poor tolerance of drugs in adults (32, 33) or the time that
follow-up appointments take, resulting in the need to be
absent from work or not having anyone to look after their
children (31).
Our study shows that there are cases of discrimination.
It was observed that the affected individuals tended to
hide the disease, fearing rejection and its consequences,
such as social isolation and the loss of employment (24,
25, 3437). The lack of awareness of the disease, fear of
being infected, and the prevalent association with dirt,
misery and rural areas were the most relevant reasons for
discrimination and rejection (25, 37, 38). Moreover, the
high prevalence of CD in Bolivia may lead to stereotypes
in certain healthcare settings, like the ‘Chagasic Bolivian’
(11). All these elements could be undermining the
development of a positive perception of what it is like
to live with Chagas.
Representation of the disease
This study has employed a transnational perspective
(39) which has been a key factor in identifying, under-
standing, and explaining the complexity of the multiple
interrelations that exist surrounding the social represen-
tation of CD (40). Evidence shows that immigrants build
their experiences and perceptions through their own past
and the multiple relationships they previously had in their
country of origin (familial, social, economic, and reli-
gious). These perceptions cross geographical, cultural,
and political borders between both countries (Bolivia
Spain).
Our data show how the social representation of the
disease ranges in a continuum from a common disease to
a deadly disease. Absence of symptoms together with the
lack of impact on day-to-day activities has contributed to
the normalisation of the illness (37, 40, 41) to the point
where Chagas is not considered a disease (25).
The standard of living in Bolivia over the past 50 years
may have influenced the perception of the disease. Until a
decade ago, it was endemic but silent. The country had
an extremely high rate of households infested with
T. infestans and a high percentage of the population was
undiagnosed yet infected and asymptomatic. Moreover,
the access to testing or specific treatment was very limited.
Likewise, healthcare policies and the media have been busy
dealing with more urgent and visible problems (natural
disasters and epidemics), the result of which is that
the disease has been largely forgotten about (24, 42). Due
to the circumstances highlighted above and given the
country’s low life expectancy, the disease has not reached
social relevance because individuals with the Chagas
infection are likely to have died from natural causes at
the age when the disease would most likely have presented
itself (25, 37). Nonetheless, during the past few years,
the standard of living has generally improved and life
expectancy has risen considerably (43). Therefore, in this
new scenario, people infected with Chagas are middle-aged
adults who are productive members of society. As such, it is
feared that the disease may result in huge economic losses
and the undermining of personal ambitions. This is the
reason why both governments and society as a whole are
starting to attribute importance to the disease and to tackle
the situation by carrying out the fumigation of houses and
providing better access to treatment (43).
The normalisation and lack of visibility of the disease
is in juxtaposition with its association with death (10, 11,
31). In countries where the healthcare system is largely
private, people generally tend to resort to home remedies
and traditional medicine until they are very unwell and
nothing can be done for them, thus creating an associa-
tion with death in the collective memory (31, 44, 45). This
would explain the gap between the collective construction
of the natural history of the disease and its reality.
Therefore, the increase in information surrounding CD
and the availability of an early diagnosis would most
likely help to alter the perception of the disease (10, 31).
Finally, thought patterns introducing the influence of
the psychological on the biological that maintain ‘the less
you know, the less you suffer’ are common amongst
Bolivian migrants (10). This can create a sizeable obstacle
in reaching this population through public health
programmes.
Strengths and limitations
The exclusion of men in the study is a limitation as it
leads to a partial understanding of what living with CD
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means for the Bolivian population residing in Madrid.
However, the inclusion of only women is also a strength
given that the control of vertical transmission during
pregnancy is one of the main priorities in non-endemic
countries.
Conclusions
Migratory flows create new public health needs and
challenges, as is the case with CD in Spain. Programmes
and healthcare providers need to take into account how
the affected persons think, how they act, and what their
life experiences are. This could improve both the control
of the disease and the quality of life of those affected (40).
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